Please provide your email address to receive an email when new articles are posted on . Published results showed percutaneous peripheral nerve stimulation may provide clinically meaningful and ...

Current Primary Outcome Measures •Numeric Rating Scale at 60 days and 90 days post procedure (lead removal) [ Time Frame: at 60 days (plus or minus 5 days) and 90 days (plus or minus 10 days) ] ...

Joseph Jeanmarie has had back problems since the 1980s, when he injured his back and had surgery. Although his chronic pain was sometimes debilitating, he continued his work as an insurance ...

SPR will feature eight abstracts on 60-day peripheral nerve stimulation (PNS) with SPRINT ® PNS that will be presented at the ...

This study is the first of its kind in developing an off-label indication for RLS. Other conditions we’re considering ...

At 8 months follow-up, patients with painful diabetic peripheral neuropathy who received spinal cord stimulation (SCS) implants reported improvements in pain, neuropathic and autonomic symptoms, ...

Spinal cord stimulators can significantly improve patients’ lives. The province doesn’t fund nearly enough of them, experts say.

Each September is Pain Awareness Month. It is an opportunity to recognize the needs of the millions of people who live with chronic pain. According to the U.S. Pain Foundation, more than 51 million ...

People with chronic back pain may turn to spinal cord stimulation to ease their pain, but a Cochrane Review found no sustained benefits to the surgery that outweigh the costs and risks. Spinal cord ...

The FDA approved the first spinal cord stimulation device (HFX) for painful diabetic neuropathy (PDN), Nevro Corp announced on Monday. The device, the only such treatment approved by the agency for ...